THE AMERICA ONE NEWS
Jun 1, 2025  |  
0
 | Remer,MN
Sponsor:  QWIKET 
Sponsor:  QWIKET 
Sponsor:  QWIKET: Elevate your fantasy game! Interactive Sports Knowledge.
Sponsor:  QWIKET: Elevate your fantasy game! Interactive Sports Knowledge and Reasoning Support for Fantasy Sports and Betting Enthusiasts.
back  
topic
Brad Matthews


NextImg:Customer DNA at 23andMe will remain private for now; CEO no longer wants to sell to a third party

DNA submitted by users to genealogy company 23andMe will remain private for now, with CEO Anne Wojcicki saying she no longer wants a third-party acquisition of the company.

The company is looking to refill its board after all of the independent directors resigned earlier this month. Ms. Wojcicki had previously dropped her opposition to a third-party takeover of the company last month, but has returned to her original position.

“I stated that I would consider third-party takeover proposals for 23andMe. … it has become even clearer to me that the best path forward for the issuer is for me to take the company private. Accordingly, in order to update my prior statement and avoid any confusion in the market, I am no longer open to considering third party takeover proposals for [23andMe],” Ms. Wojcicki said in the SEC filing.

If 23andMe were sold to a third party, the buyer could theoretically sell or use the data collected by it previously for other purposes. In a filing to the Securities and Exchange Commission Monday, Ms. Wojcicki said that “I remain committed to our customers’ privacy and pledge to maintain the issuer’s current privacy policy in effect for the foreseeable future.”

Ms. Wojcicki, a co-founder of the company, has 49% of voting power and owns more than 20% of all company shares.

The company does prompt users to choose whether they want their data to be available for use in genetic and medical research, with about 80% choosing to allow their data to be used.

“For our customers, our focus continues to be on transparency and choice over how they want their data to be managed,” 23andMe spokesperson Andy Kill told NPR, adding that the 80% rate has “held steady for many years.”

Law enforcement is not allowed to access the 23andMe database, Mr. Kill said. 23andMe extended its initial research agreement with pharmaceutical giant GlaxoSmithKline for an additional year in October 2023.

The company has previously been the victim of a data breach in 2023, which saw 14,000 accounts and about 6.9 million associated DNA profiles accessed by hackers. The company reached a $30 million settlement in a class-action lawsuit concerning the breach last month, according to The Associated Press.

• Brad Matthews can be reached at bmatthews@washingtontimes.com.